CELZ - CIK 0001187953
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. trades as CELZ. In its fiscal 2025 annual report the company posted revenue of $6.00K, down 45.5% from the prior year and net income of -$6.00M. This page tracks CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. through 393 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin compressed from -55398.1% to -99916.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-08 |
| Annual report (amended) | 10-K/A | 2026-04-24 |
| Annual report | 10-K | 2026-03-20 |
| Major company event | 8-K | 2025-12-31 |
| Major company event | 8-K | 2025-12-19 |
| 424B3 | - | 2025-12-16 |
| EFFECT | - | 2025-12-12 |
| Securities registration | S-3 | 2025-11-21 |
The largest companies sharing CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s SEC industry classification (biological products, (no diagnostic substances)).
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported revenue of $6.00K for fiscal year 2025, a decrease of 45.5% year over year.
In its latest fiscal year CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported a net loss of $6.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.